{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:03:31Z","timestamp":1778929411423,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"vor","delay-in-days":304,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2016]]},"DOI":"10.6061\/clinics\/2016(10)12","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T10:34:11Z","timestamp":1480588451000},"page":"626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Profibrotic pathways and atrial cardiomyopathy in persistent atrial fibrillation"],"prefix":"10.1016","volume":"71","author":[{"given":"U\u011fur","family":"Canpolat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.6061\/clinics\/2016(10)12_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.6061\/clinics\/2016(05)02","article-title":"The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation","volume":"71","author":"Wu","year":"2016","journal-title":"Clinics"},{"issue":"7","key":"10.6061\/clinics\/2016(10)12_bib2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1540-8167.2012.02341.x","article-title":"Fibrotic atrial cardiomyopathy: a specific disease\/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications","volume":"23","author":"Kottkamp","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"10.6061\/clinics\/2016(10)12_bib3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.2003.015347","article-title":"Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease","volume":"90","author":"Boldt","year":"2004","journal-title":"Heart"},{"issue":"3","key":"10.6061\/clinics\/2016(10)12_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jce.12578","article-title":"A prospective DE-MRI study evaluating the role of TGF-beta1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy","volume":"26","author":"Canpolat","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"13","key":"10.6061\/clinics\/2016(10)12_bib5","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/CIRCULATIONAHA.108.811877","article-title":"Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation","volume":"119","author":"Oakes","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.6061\/clinics\/2016(10)12_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation","volume":"51","author":"Burstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.6061\/clinics\/2016(10)12_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5543\/tkda.2015.83893","article-title":"Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study","volume":"43","author":"Canpolat","year":"2015","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"3","key":"10.6061\/clinics\/2016(10)12_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059052","article-title":"Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study","volume":"8","author":"Huxley","year":"2013","journal-title":"PloS One"},{"issue":"12","key":"10.6061\/clinics\/2016(10)12_bib9","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/jce.12818","article-title":"Primary Persistent Atrial Fibrillation: A Distinct Arrhythmia Subentity of an Ablation Population","volume":"26","author":"Konrad","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"19","key":"10.6061\/clinics\/2016(10)12_bib10","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","article-title":"Approaches to catheter ablation for persistent atrial fibrillation","volume":"372","author":"Verma","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222010511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222010511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:57:33Z","timestamp":1761721053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222010511"},"secondary":[{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5054772\/?report=classic","label":"PMC"},{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322016001000626&lng=en&nrm=iso&tlng=en","label":"SCIELO"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"alternative-id":["S1807593222010511"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2016(10)12","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profibrotic pathways and atrial cardiomyopathy in persistent atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2016(10)12","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}